Related Experiment Video
Updated: Sep 2, 2025
08:05
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
2.9K
Immune remodeling and atrial fibrillation
Yajun Yao1,2,3, Mei Yang1,2,3, Dishiwen Liu1,2,3
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Frontiers in Physiology
|August 8, 2022
Summary
Immune remodeling plays a key role in atrial fibrillation (AF) pathophysiology. Understanding these immune changes may lead to novel immunomodulatory treatments for AF.
Area of Science:
- Cardiology
- Immunology
- Pathophysiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia with significant morbidity and mortality.
- The precise mechanisms driving AF remain incompletely understood.
- Emerging evidence links immune system alterations to AF initiation and progression.
Purpose of the Study:
- To review the concept of immune remodeling in AF.
- To explore the interplay between immune remodeling and atrial electrical, structural, and neural changes.
- To discuss potential immunomodulatory therapeutic strategies for AF.
Main Methods:
- Literature review of existing data on immune remodeling in AF.
- Analysis of the relationship between immune system changes and AF pathophysiology.
- Discussion of current research gaps and future directions.
Main Results:
- Immune system modifications are increasingly recognized in AF.
- Immune remodeling is intricately connected with electrical, structural, and neural remodeling in the atria.
- Several potential immunomodulatory treatments for AF have been identified.
Conclusions:
- Immune remodeling is an evolving area in AF pathophysiology.
- Further research is needed to clarify the role of the immune system in AF.
- Targeting immune pathways may offer future therapeutic avenues for AF, despite current evidence heterogeneity.
More Related Videos
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
497
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
497
01:23Rheumatic Heart Disease I: Introduction
36
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
36
01:25Aortic Regurgitation III: Medical Management
38
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
38
01:21Myocarditis I: Introduction
25
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
23
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
01:14Myocarditis III: Medical Management
14
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14